Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 356, P. 316 - 336
Published: March 9, 2023
Language: Английский
Journal of Controlled Release, Journal Year: 2023, Volume and Issue: 356, P. 316 - 336
Published: March 9, 2023
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2023, Volume and Issue: 243, P. 125199 - 125199
Published: June 6, 2023
Language: Английский
Citations
57International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 296, P. 139710 - 139710
Published: Jan. 9, 2025
Language: Английский
Citations
3International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 295, P. 139551 - 139551
Published: Jan. 7, 2025
Language: Английский
Citations
2Journal of Materials Chemistry B, Journal Year: 2022, Volume and Issue: 10(31), P. 5853 - 5872
Published: Jan. 1, 2022
As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel disease (IBD) is characterized by recurrent intestinal mucosal inflammation.
Language: Английский
Citations
57Food Hydrocolloids, Journal Year: 2022, Volume and Issue: 133, P. 107958 - 107958
Published: July 9, 2022
Pectin is a group of structurally diverse dietary fibers, very abundant in agri-food waste and by-products such as those generated during apple cider manufacturing. In recent years, pectin pectinoligosaccharides have demonstrated good fermentation properties prominent health promoting traits, particularly ameliorating certain inflammatory conditions. previous investigations pomace derived from production monovarietal Asturian ciders was to represent source with varied structural characteristics. this work we investigated vitro the modulatory effect fractions selected on human microbiota healthy subjects bowel disease (IBD) patients through fecal batch fermentations 16S rRNA gene sequencing. Overall, these promoted growth Akkermansia, Lachnospiraceae UCG-010, Prevotella, Sucinivibrio Turicibacter samples donors, while Blautia, CAG-56, Dialister, Eubacterium eligens Intestinimonas were stimulated IBD patients. The E. group, Succinivibrio only occurred tested by-products, not other non-pectic prebiotics/substrates. Galactose content (Arabinose + Galactose)/Rhamnose ratio pomace, galactose rhamnose pectin, positively associated promotion most genera. This comprehensively characterize gut modulation demonstrating capacity distinct fractions. diversifies opportunities achieve valorization formulation novel prebiotics for particular population groups.
Language: Английский
Citations
50Advanced Science, Journal Year: 2023, Volume and Issue: 10(31)
Published: Sept. 22, 2023
Modulating the inflammatory microenvironment can inhibit process of diseases (IDs). A tri-cross-linked microenvironment-responsive hydrogel with ideal mechanical properties achieves triggerable and sustained drug delivery regulates microenvironment. Here, this study develops an (OD-PP@SeNPs) composed phenylboronic acid grafted polylysine (PP), oxidized dextran (OD), selenium nanoparticles (SeNPs). The introduction SeNPs as initiators nano-fillers into results in extra cross-linking polymer network through hydrogen bonding. Based on Schiff base bonds, Phenylboronate ester a reactive oxygen species (ROS)/pH dual responsive triple-network is achieved. has injectable, self-healing, adhesion, outstanding flexibility, suitable swelling capacity, optimal biodegradability, excellent stimuli-responsive active substance release performance, prominent biocompatibility. Most importantly, ROS scavenging pH-regulating ability protects cells from oxidative stress induces macrophages M2 polarization to reduce cytokines PI3K/AKT/NF-κB MAPK pathways, exerting anti-inflammatory effects reshaping microenvironment, thereby effectively treating typical IDs, including S. aureus infected wound rheumatoid arthritis rats. In conclusion, dynamically injectable structure provides effective strategy treat holding great promise clinical application.
Language: Английский
Citations
40Journal of Nanobiotechnology, Journal Year: 2023, Volume and Issue: 21(1)
Published: Aug. 18, 2023
Due to oral nano-delivery systems for the treatment of inflammatory bowel disease (IBD) are often failed accumulated colonic site and could not achieve controlled drug release, it's urgent develop a microenvironment responsive delivery improve therapy efficacy. Inflammation at IBD is mainly mediated by macrophages, which key effector cells. Excessive inflammation leads oxidative stress intestinal mucosal damage. The use curcumin (CUR) emodin (EMO) together promising due their respective anti-inflammatory repair effects. In view pH gradient environment gastrointestinal tract, here we prepared pH-responsive sodium alginate (SA) hydrogel-coated nanoemulsions co-deliver CUR EMO (CUR/EMO NE@SA) release specifically target macrophages colon.In this study, CUR/EMO NE@SA was successfully developed, in NE loaded chitosan further crosslinked with alginate. had property colon. preparation significantly alleviate colon decreasing TNF-α IL-6 expression, increasing IL-10 scavenging reactive oxygen species ameliorating restoration tight junction protein expression. Furthermore, revealed molecular mechanism treatment, might synergic inhibition NF-κB pro-inflammatory microenvironment. Our study provides new strategy via synergically inhibiting inflammatory, repairing clearing ROS pH-sensitive hydrogel-encapsulated nanoemulsion system, be developed other chronic treatment.It's suggested that nanoemulsion-based codelivery combinatorial platform IBD.
Language: Английский
Citations
33Carbohydrate Polymers, Journal Year: 2023, Volume and Issue: 314, P. 120887 - 120887
Published: April 11, 2023
Language: Английский
Citations
30Advanced Healthcare Materials, Journal Year: 2023, Volume and Issue: 12(19)
Published: March 16, 2023
Abstract Inflammatory bowel disease (IBD), a chronic and recurrent gastrointestinal inflammatory disorder with variety of painful clinical manifestations an increased risk cancerization or death, has become emerging challenge to global healthcare due its rapidly increasing incidence. At present, there is no efficient cure against IBD because the elusive etiology pathogenesis IBD. Therefore, development alternative therapeutic strategies positive efficacy reduced side effects urgently needed. In recent years, great prosperity nanomedicine promoted by advanced nanomaterials redefining more attractive promising for owing their advantages in physiological stability, bioavailability, targeting sites. this review, firstly basic characteristics healthy intestinal microenvironments are presented. Then, different administration routes nanotherapeutics treatment reviewed. Subsequently, specific focus placed on introduction nanotherapeutic treatments based pathogenesis. Finally, some future challenges perspectives currently developed nanomedicines provided. It believed that above topics will attract researchers from various fields including medicine, biological sciences, materials, chemistry pharmaceutics.
Language: Английский
Citations
26Carbohydrate Polymers, Journal Year: 2023, Volume and Issue: 316, P. 121025 - 121025
Published: May 23, 2023
Language: Английский
Citations
24